ARTICLE | Emerging Company Profile
Wound-up bacteria
Ilya delivers CXCL12 via engineered bacteria to speed wound healing
July 27, 2018 7:11 PM UTC
Ilya Pharma AB has engineered bacteria to produce a protein that promotes wound closure as a more convenient and lower cost alternative to recombinant protein therapies that accelerate wound healing.
According to CEO Evelina Vågesjö, the standard of care to treat wounds involves cleaning the wound site and re-dressing the wound about every three days. For acute wounds, antibiotics may be added to prevent infection. ...